Abstract
Amodiaquine remains one of the most prescribed antimalarial 4-aminoquinoline. To assess the importance of the 4-hydroxyl group and subsequent hydrogen bond in the antimalarial activity of amodiaquine (AQ), a series of new analogues in which this functionality was replaced by various amino groups was synthesized. The incorporation of a 3- pyrrolidinamino group instead of the 3-diethylamino function of AQ allowed the development of a parallel series of amopyroquine derivatives. The compounds were screened against both chloroquine (CQ)-sensitive and – resistant strains of Plasmodium falciparum and their cytotoxicity evaluated upon the MRC5 cell line. Antimalarial activity in a low nanomolar range was recorded showing that the 4-hydroxy function can be successfully replaced by various amino substituents in terms of activity without any influence of the level of CQ-resistance of the strains. Furthermore the ability of the compounds to inhibit beta-hematin formation was measured in order to discuss the mechanism of action of these new compounds. Compounds 7d and 8d exhibit a high selectivity index and may be considered as promising leads for further development.
Keywords: Antimalarials, 4-aminoquinolines, amodiaquine, Plasmodium falciparum
Medicinal Chemistry
Title: Synthesis and Antimalarial Activity of New Amino Analogues of Amodiaquine
Volume: 4 Issue: 5
Author(s): E. Paunescu, S. Susplugas, E. Boll, R. A. Varga, E. Mouray, P. Grellier and P. Melnyk
Affiliation:
Keywords: Antimalarials, 4-aminoquinolines, amodiaquine, Plasmodium falciparum
Abstract: Amodiaquine remains one of the most prescribed antimalarial 4-aminoquinoline. To assess the importance of the 4-hydroxyl group and subsequent hydrogen bond in the antimalarial activity of amodiaquine (AQ), a series of new analogues in which this functionality was replaced by various amino groups was synthesized. The incorporation of a 3- pyrrolidinamino group instead of the 3-diethylamino function of AQ allowed the development of a parallel series of amopyroquine derivatives. The compounds were screened against both chloroquine (CQ)-sensitive and – resistant strains of Plasmodium falciparum and their cytotoxicity evaluated upon the MRC5 cell line. Antimalarial activity in a low nanomolar range was recorded showing that the 4-hydroxy function can be successfully replaced by various amino substituents in terms of activity without any influence of the level of CQ-resistance of the strains. Furthermore the ability of the compounds to inhibit beta-hematin formation was measured in order to discuss the mechanism of action of these new compounds. Compounds 7d and 8d exhibit a high selectivity index and may be considered as promising leads for further development.
Export Options
About this article
Cite this article as:
Paunescu E., Susplugas S., Boll E., Varga A. R., Mouray E., Grellier P. and Melnyk P., Synthesis and Antimalarial Activity of New Amino Analogues of Amodiaquine, Medicinal Chemistry 2008; 4 (5) . https://dx.doi.org/10.2174/157340608785700153
DOI https://dx.doi.org/10.2174/157340608785700153 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators
Current Topics in Medicinal Chemistry Target-Related Affinity Profiling: Teliks Lead Discovery Technology
Current Topics in Medicinal Chemistry Functional Effects of Levosimendan in Rat Basilar Arteries In Vitro
Current Neurovascular Research The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Current Pharmaceutical Design GASPIDs <i>Versus</i> Non-GASPIDs - Differentiation Based on Machine Learning Approach
Current Bioinformatics Asafoetida, Natural Medicine for Future
Current Nutrition & Food Science Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Vitamin D: A Regulator of Metabolism and Inflammation
Current Nutrition & Food Science Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine Panicogens in Patients with Post-Traumatic Stress Disorder (PTSD)
Current Pharmaceutical Design Formulation Strategies and Particle Engineering Technologies for Pulmonary Delivery of Biopharmaceuticals
Current Pharmaceutical Design Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design The Future of Collateral Artery Research
Current Cardiology Reviews Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Reviews on Recent Clinical Trials Cyclophilins in Atherosclerosis: A New Therapeutic Target?
Current Pharmaceutical Design Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier
Current HIV Research